Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic H5N1 Influenza”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01195038
What this trial is testing

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Who this might be right for
Influenza
UMN Pharma Inc. 87
Early research (Phase 1)Study completedNCT01236040
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 521
Testing effectiveness (Phase 2)Study completedNCT04669691
What this trial is testing

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

Who this might be right for
Influenza, Human
Seqirus 420
Large-scale testing (Phase 3)Looking for participantsNCT07240558
What this trial is testing

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

Who this might be right for
Influenza (Pandemic)Avian InfluenzaVaccination
University Health Network, Toronto 120
Testing effectiveness (Phase 2)Study completedNCT01766921
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 1,393
Early research (Phase 1)Study completedNCT00755703
What this trial is testing

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Who this might be right for
Influenza A Subtype H5N1 Infection
Altimmune, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Large-scale testing (Phase 3)Study completedNCT00434733
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects

Who this might be right for
Influenza
Novartis 4,400
Early research (Phase 1)Study completedNCT00532792
What this trial is testing

A/H5N1 Dose Ranging Study With Adjuvant Patch

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 501
Early research (Phase 1)Study completedNCT01511419
What this trial is testing

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Who this might be right for
InfluenzaAvian Influenza
PATH 40
Early research (Phase 1)Study completedNCT02480101
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

Who this might be right for
Influenza
Research Institute of Influenza, Russia 40
Early research (Phase 1)Study completedNCT01596725
What this trial is testing

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

Who this might be right for
Influenza (Pandemic)
Novavax 333
Testing effectiveness (Phase 2)Study completedNCT02078674
What this trial is testing

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

Who this might be right for
Influenza (Pandemic)
Novavax 610
Testing effectiveness (Phase 2)Study completedNCT00719043
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years

Who this might be right for
Influenza
GlaxoSmithKline 841
Early research (Phase 1)Study completedNCT00783926
What this trial is testing

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 422
Testing effectiveness (Phase 2)Study completedNCT00397215
What this trial is testing

Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 437
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Testing effectiveness (Phase 2)WithdrawnNCT01045564
What this trial is testing

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
Influenza
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT06382311
What this trial is testing

Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 991
Next Page